University Health Network (UHN)/Toronto General Hospital (TGH)
Johane P. Allard is Professor of Medicine at the University of Toronto, Toronto, Canada and is crossed-appointed at the Department of Nutritional Sciences and Institute of Medical Sciences. She trained in gastroenterology at McGill University before completing a research fellowship funded by the National Institute of Nutrition at the University of Toronto.
Dr. Allard is a clinician investigator, with a research focus in nutrition and gastrointestinal disorders. She is currently conducting several studies funded by peer-reviewed agencies in patients requiring nutrition support, people with non-alcoholic steatohepatitis (NASH) and patients with morbid obesity undergoing bariatric surgery. She is also conducting research on malnutrition in Canadian hospitals and has developed a research program on the intestinal microbiome related to the Metabolic-Syndrome. Her publications are primarily in the area of micronutrients, oxidative stress, nutrition support and NASH.
Dr. Allard is also the Director of the Division of Gastroenterology at the University of Toronto and the Director of the Nutrition Support Program at the University Health Network (UHN). She works with a multidisciplinary nutrition support team and is the Chair of the Nutrition Review Committee. She is also the past-chair the Royal College of Physician and Surgeon Examining Board in Gastroenterology and co-founder of the Canadian Nutrition Society and member of its Advisory Board.
Dr. Mamatha Bhat graduated from medical school at McGill University, followed by Internal Medicine and Gastroenterology residency training at the McGill University Health Centre. This was followed by a Resident Physician Health Research Career Training fellowship funded by the Fonds de Recherche du Quebec – Sante (FRQS), through which she completed an MSc in Experimental Medicine and the Royal College Clinician Investigator Program. Dr. Bhat went on to do a fellowship in Transplant Hepatology at Mayo Clinic in Rochester, Minnesota with mentorship from Dr. Gregory Gores. She then continued research training with Dr. Nahum Sonenberg at McGill University through a Fellowship for Health Professionals from the Canadian Institutes for Health Research (CIHR), during which she studied mRNA translation in hepatocellular carcinoma. She was concomitantly a Staff Hepatologist at the Royal Victoria Hospital.
Dr. Bhat is currently a staff Hepatologist and clinician-scientist within the UHN Multi Organ Transplant Program and the UofT Gastroenterology Division, where she is developing innovative systems biology methods to link basic science with clinical outcomes. Her current research mandate is to develop a precision medicine program in hepatocellular carcinoma, non-alcoholic steatohepatitis, and liver regeneration in the context of liver transplantation.
Dr. Feld graduated from medical school at the University of Toronto in 1997 and then completed residency programs in Internal Medicine and Gastroenterology. Following his clinical training, Dr. Feld completed a clinical research fellowship in hepatology and then spent 4 years doing clinical and laboratory research in the Liver Diseases Branch of the National Institutes of Health. He received a Masters of Public Health from Johns Hopkins University and has worked extensively abroad, maintaining a strong interest in International Health.
Dr. Feld returned to Toronto to join the faculty of the University of Toronto as an Assistant Professor of Medicine and clinician-scientist based at the Toronto Western Hospital Liver Center and the Sandra Rotman Centre for Global Health. His laboratory focuses on understanding treatment non-response in hepatitis C infection and more broadly on understanding the antiviral immune response with the goal of developing new strategies for the treatment of viral hepatitis.
Dr. Scott Fung completed his medical training in Internal Medicine and Gastroenterology at the University of Toronto. During his training in Hepatology, he studied the natural history and treatment of hepatitis B at Queen Mary Hospital at the University of Hong Kong. He pursued postdoctoral training in Hepatology at the University of Michigan in Ann Arbor. Dr. Fung's research interests include clinical trials in viral hepatitis B and C, clinical epidemiology of viral hepatitis and management of antiviral-resistant hepatitis B. He has co-authored several papers on the natural history and management of chronic viral hepatitis and serves as a reviewer for international journals in Gastroenterology and Hepatology.
Dr. Fung is currently appointed to the Divisions of Gastroenterology and General Internal Medicine at University Health Network and Mount Sinai Hospital and is an Assistant Professor of Medicine in the Department of Medicine at the University of Toronto. He is the site director of Gastroenterology education at Toronto General Hospital and a member of the University of Toronto Gastroenterology Education Committee. Dr. Fung is a member of the governing board of the Canadian Association for the Study of the Liver and he also volunteers for the Royal College of Physicians and Surgeons of Canada.
Dr. Habal received his MD and his PhD in Pathology from the University of Toronto (1975). He subsequently trained in Internal Medicine and in Gastroenterology at the University of Toronto, following which he joined the full-time faculty. Dr. Habal is currently an Associate Professor of Medicine and staff physician at the Toronto General Hospital. Dr. Habal's clinical interests are in the areas of acid related disorders and inflammatory bowel disease in pregnancy. He also has interest in hepatitis C and liver disease.
Since 1990 Dr. Habal has served as a member of the drug review board of the United state Pharmacopere (USP). Since 1999, Dr. Habal has served as Chair of the Pharmacy and Therapeutics Committee at the University Hospital Network. Dr Habal is presently the Education Chair of the Canadian Digestive Health Foundation.
Harry Janssen is Professor of Medicine, Francis Family Chair in Hepatology and Head of the Liver Clinic at Toronto Western and Toronto General Hospital, University Health Network, Toronto, Canada.
Harry Janssen (1964) graduated from medical school at the Radboud University of Nijmegen, the Netherlands. During his study he spent one year as research fellow in Hepatology at the Mayo Clinic. He obtained his PhD in Rotterdam on the role of immune modulating therapy in chronic hepatitis B. He then trained in Internal Medicine at Leiden University Medical Center and in Gastroenterology & Hepatology at Rotterdam Erasmus University Medical Center. Following his registration as Gastroenterologist he returned to the Mayo Clinic for a research fellowship in Hepatology at the Center of Basic Research in Digestive Diseases. In 2001 he became a staff member and in 2006 he was appointed as full professor of Hepatology and Chief of the Section Liver Diseases and Transplantation in Rotterdam.
As principle investigator prof. Janssen coordinated numerous European and global multicenter studies on antiviral treatment for chronic viral hepatitis. He was awarded a Clinical Fellowship and an Innovational Research grant from the Netherlands Organisation of Scientific Research to study strategies of immune control in viral hepatitis and published many international articles on this subject. Professor Janssen has been chairman of the Dutch Association of Hepatology and was elected as Rising Star in Gastroenterology and Hepatology by the Association of the National European Societies of Gastroenterology. He has been member of the editorial board of Hepatology, Journal of Hepatology and Best Practice in Gastroenterology. He has published over 260 original peer-reviewed papers. In addition to his longstanding expertise in antiviral therapy of chronic viral hepatitis, professor Janssen is a leading scientist in the field of vascular disorders of the liver.
Dr. Levy graduated from medical school at the University of Toronto in 1973. Following postdoctoral training in immunology at the Scripps Clinic and Research Foundation he returned to the University of Toronto. Since 1990, he has been the Director of the Multi Organ Transplant Program at the University Health Network. He is currently a Professor in the Departments of Medicine and Surgery at the University of Toronto and the Director of the University of Toronto Transplant Institute.
He has received numerous honors including:
- Recipient of the William Goldie Prize in Medicine
- Election to the American Society for Clinical Investigation
- Recipient of the Canadian Liver Foundation Commemorative Medal for the Queen’s Jubilee for his outstanding contribution to the study of liver disease
- Recipient of the Ivan T. Beck Lectureship from the Canadian Association of Gastroenterology (CAG)
- Recipient of the Dr. Richard Hunt Outstanding Service Award from the Canadian Digestive Health Foundation
- Awarding of Williams Calne Lectureship for his outstanding contribution to the study of liver disease from the British Association for the Study of the Liver
- Elected as a Fellow of the American Gastroenterological Association
- Member of the Doctors Lions Club District A-711
In addition to his clinical and administrative duties, he has achieved international recognition for his research in studies of the immunopathogenesis of viral hepatitis, transplant rejection and tolerance. He has published over 350 peer reviewed articles and has trained over 60 Masters and PhD students.
Dr. Lilly received his MD from McMaster University (1986) and completed his Internal Medicine and Gastroenterology training at the University of Toronto (1991). He undertook post-graduate training at Brigham & Women's Hospital in Boston (1991-1995). In 1995, Dr. Lilly joined the staff at the University Health Network (UHN), where he is Medical Director, Gastrointestinal Transplantation. Dr. Lilly's research interests include hepatitis B and C in solid organ transplantation.
Dr. Renner graduated from Medical School at the University of Basel, Switzerland, in 1979 and completed a research thesis in the Department of Clinical Immunology at the University of Bern, Switzerland, in 1981. After post-graduate training in Internal Medicine and Gastroenterology/Hepatology at the Universities of Bern and Basel, Switzerland, and during a fellowship at the University of California, San Francisco, he came on faculty at the University of Berne, Switzerland, in 1994. From 1997 to 2003, Dr. Renner served as Head of Hepatology, Medical Director of the Liver Transplant Program and Vice-Chairman of the Division of Gastroenterology and Hepatology at the University Hospital, Zurich, Switzerland. He moved to Canada in 2004 and served until August 2007 as a Professor of Medicine and Pharmacology and Director of the Liver Transplant Program at the University of Manitoba. In September 2007, he was recruited to his current position at U of T/TGH.
Dr. Hemant Shah is an Assistant Professor, Staff Hepatologist and Clinician-Educator at the Francis Family Liver Clinic, Toronto Western Hospital, University of Toronto. His clinical focus is viral liver disease and he maintains a busy teaching practice. In addition to clinical care, Dr. Shah is actively engaged in projects to develop innovative models of care for viral hepatitis, progress interprofessional collaboration and improve knowledge levels amongst primary care and specialty providers. He also serves as Program Director of the Hepatology Fellowship, which trains three to five clinical and research fellows annually. Dr. Shah has graduate training in Health Practitioner Education.
Dr. Sherman graduated in Medicine from the University of Witwatersrand in Johannesurg South Africa in 1972, and completed his initial training in Internal Medicine at Baragwanath Hospital in Soweto. Dr. Sherman obtained his Internal Medicine qualifications in 1976 and completed his Internal Medicine training at Groote Schuur Hospital, Cape Town South Africa. He undertook training in Gastroenterology and liver disease at Groote Schuur Hospital and then completed a PhD in 1982 in the Liver Research laboratory of the University of Cape Town. In 1982, Dr. Sherman undertook a 2 year post doctoral fellowship at the Albert Einstein College of Medicine in New York. Dr. Sherman joined the Toronto General Hospital as a staff gastroenterologist in 1984.
Dr. Sherman is currently Chairman of the Canadian Viral Hepatitis Network and President of the Canadian Association for Study of the Liver. His major interests are chronic viral hepatitis and hepatocellular carcinoma.
Dr. Wolman received his MD degree (1974), as well as his training in Internal Medicine and Gastroenterology at the University of Toronto. He then trained as a Research Fellow at the London School of Hygiene and Tropical Medicine (1980-82). Since 1982, he has been a staff physician at the Toronto General Hospital and an Assistant Professor of Medicine. Dr. Wolman's clinical interests include nutrition and inflammatory bowel disease.
Dr. David Wong is a hepatologist in Toronto, Ontario. He graduated from the University Of Toronto Faculty Of Medicine in 1988. Following his clinical training in Internal Medicine and Gastroenterology, Dr. Wong received further training as a research fellow with Dr. Bruce Walker at the Massachusetts General Hospital, Harvard Medical School, where he studied the cellular immune responses to hepatitis C viral infection.
Dr. Wong was initially appointed full time staff in the Division of Gastroenterology at McMaster University in 2000 and then moved to the University Health Network (UHN)/Mount Sinai Hospital (MSH) in 2002, where he is the Clinical Director of the Toronto Western Hospital Francis Family Liver Center, University Health Network. He is also on staff of the Immunodeficiency Clinic at UHN - Toronto General Division and is currently an Assistant Professor of Medicine at the University of Toronto. He is also the staff hepatologist at the Specialized Positive Care Clinic at St. Michael’s Hospital.
Dr. Wong's clinical interests lie in the area of viral hepatitis and liver disease in HIV. His educational responsibilities include coordinating the Clinical Hepatology training program for the University of Toronto. He is an advisor to the Hepatitis C Secretariat at the Ministry of Health and Long-Term Care. Dr. Wong also co-ordinates the annual Hepatology Update meeting in Toronto.
Dr. Florence Wong graduated with an MBBS from the University of Melbourne, Australia in 1978. After undergoing further training in ascites pathogenesis in cirrhosis and receiving her doctorate degree in medicine from Monash University, Australia in 1993, she joined the University of Toronto in the GI Division as a faculty member in 1997. Currently, she is a Professor of Medicine at the University of Toronto, and divides her time between patient care and research. Her research interests include pathogenesis of portal hypertension, ascites formation, liver-kidney interaction, including the development of hepatorenal syndrome, and renal failure in cirrhosis. She has published over 150 peer-reviewed journal articles, reviews, book chapters and editorials in these areas. Most recently, she has been responsible for putting together a landmark international document defining renal failure in cirrhosis. She is currently working in a North American consortium assessing the effects of infection on renal function in cirrhosis. She has held many national and international research-related positions, including membership of the Clinical Research Committee of the American Association for the Study of Liver Diseases, Chair for the Abstract Review Committee in the Section of Portal Hypertension & Complications of Cirrhosis for the American Association for the Study of the Liver, Secretary of the International Ascites Club, as well as the Chair of the Education Committee of the Canadian Association for the Study of the Liver. She is currently a member of the Editorial Board for several prestigious journals including Gut and Hepatology. In addition, she is a regular grant reviewer for various international funding agencies including the National Institutions of Health of the USA, the Canadian Institutes for Health Research, the Wellcome Trust of the United Kingdom, Swiss National Science Foundation and The Netherlands Organisation for Health Research and Development.